Alprostadil/lidocaine - Seelos Therapeutics
Alternative Names: NM02216; NM100061Latest Information Update: 29 Jan 2019
At a glance
- Originator NexMed
- Developer Apricus Biosciences
- Class Acetanilides; Erectile dysfunction therapies; Monounsaturated fatty acids; Prostaglandins; Small molecules
- Mechanism of Action Prostaglandin E1 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Premature ejaculation